COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

Europe's medicines ‌regulator ‌on Friday recommended ​granting marketing authorisation to mCombriax, ‌making ⁠Moderna's messenger RNA vaccine ⁠the world's ​first ​combined ​shot for ...

Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million ...

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million ...

Thank you, Kevin. Good morning, everyone, and thank you for joining us on today’s call to discuss Moderna, Inc.’s fourth quarter 2025 financial results and business update. On today’s call are ...

The U.S. women's figure skating team is seeking its first gold medal in 24 years. The "Blade Angels" participated in the first part of their competition on Tuesday, with Alysa Liu placing third, while ...

Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a little more than a year in the role. As of publication, Moderna has not responded to Fierce Biotech’s questions about a ...

The recent downturn follows Moderna’s announcement that its melanoma vaccine, mRNA-4157, showed promising results in a Phase 2b study, reducing the risk of recurrence or death by 49% when combined ...

What To Know: Moderna said it expects 2025 revenue of approximately $1.9 billion, which is $100 million above the midpoint previously communicated during its third-quarter earnings call. The company ...

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see Moderna hand over just $3 ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The story of the biotech company Moderna almost reads like a ...

Improves 2025 expected GAAP operating expenses by $0.7 billion to a range of $5.2 – $5.4 billion Increases 2025 expected year-end cash balance by $0.5 billion – $1 billion to a range of $6.5 – $7.0 ...